The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Topamax 200 mg film-coated tablets



Originalis B.V.PPA2306/003/001

Main Information

Trade NameTopamax 200 mg film-coated tablets
Active SubstancesTopiramate
Dosage FormFilm-coated tablet
Licence HolderOriginalis B.V.
Licence NumberPPA2306/003/001

Group Information

ATC CodeN03AX Other antiepileptics
N03AX11 topiramate

Status

License statusAuthorised
Licence Issued15/02/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back